Pyro Pharmaceuticals, Fero Industries Inc. deal

Infectious disease company Pyro will reverse-merge with shell company Fero. Pyro shareholders will receive 38.3 million existing Fero shares valued at $16.9 million based on Fero's close of $0.44 on October 13, the day before the deal was announced. Pyro shareholders will own 60% of the newco, and Fero shareholders will own the remaining 40%. Upon the deal closing, which is expected by year end, Fero plans to raise between $500,000 and $1.5 million through the placement of notes. ...